SAN FRANCISCO (Diya TV) — Artificial intelligence is rapidly reshaping healthcare and life sciences, with startups and established companies racing to streamline operations, improve patient care, and speed up medical innovation. New developments from AI-driven life sciences startup Collate, identity verification company Clear, and clinical AI provider Harrison.ai highlight how technology is transforming key areas of the healthcare industry.
The latest wave of healthcare AI investment comes as organizations seek to reduce paperwork, improve efficiency, and address growing demands on medical systems worldwide.
Healthcare AI startup Collate has raised $95 million in new funding, less than two years after emerging from stealth mode. The funding round values the San Francisco-based company at nearly $1 billion. Founded by entrepreneur Surbhi Sarna and co-founder Nate Smith, Collate develops AI tools that help life sciences companies manage large volumes of regulatory, clinical trial, and product development documents.
The company has experienced rapid growth since signing its first customer in May 2025. It now serves more than 50 clients, including major pharmaceutical companies, medical device manufacturers, and publicly traded biotechnology firms. Sarna believes life sciences documentation will become one of the most important AI markets in the coming years. The industry faces enormous paperwork demands, with some regulatory submissions reaching 10,000 pages.
Collate says its platform can reduce documentation workloads by 50% to 90%. Tasks that once required several months can now be completed in weeks. The company also requires human review before documents leave its system, helping maintain accuracy and patient safety. The growing adoption of AI in life sciences reflects a broader industry trend. Companies increasingly seek technology solutions that shorten development timelines and help bring new treatments to patients faster.
Clear, best known for its biometric identity verification services at airports, is making a significant push into healthcare. The company generated $900 million in revenue and $168 million in net income during 2025 from its core biometric security business. Now, CEO Caryn Seidman Becker is focusing on expanding Clear’s presence in hospitals and healthcare systems. Several major healthcare organizations across Georgia, New York, New Jersey, and Louisiana have adopted Clear’s technology. Hospitals use facial recognition tools to verify patient identities during appointments, surgeries, and cancer treatments.
Healthcare providers also use the technology to simplify account access and password recovery for patient portals. In December, Clear secured a $6 million contract with Medicare that allows new enrollees to access accounts using selfie-based verification instead of traditional passwords. As healthcare organizations face growing cybersecurity risks and identity fraud concerns, biometric authentication is becoming an increasingly attractive solution.
Australian clinical AI company Harrison.ai is also accelerating its growth plans. Founded in 2018 by brothers Aengus Tran and Dimitry Tran, the company develops AI software that helps radiologists analyze medical images and create diagnostic reports. The company’s technology reviews chest X-rays and CT scans, identifies potential issues, and prioritizes urgent cases. Harrison.ai says its software can reduce report turnaround times by up to 40% for critical cases while improving overall reporting efficiency.
Today, more than 3,400 clinicians use Harrison.ai’s products across more than 1,000 hospitals and clinics in 40 countries. The company has become a major player in Australia and the United Kingdom. It serves roughly half of Australia’s registered radiologists and evaluates more than 40% of chest X-rays for NHS England. Now Harrison.ai is preparing for a major expansion into the United States. The company believes the U.S. healthcare market offers significant growth opportunities as hospitals increasingly adopt AI-powered diagnostic tools.
The rapid growth of companies such as Collate, Clear, and Harrison.ai highlights the expanding role of artificial intelligence in healthcare. From reducing paperwork and streamlining regulatory processes to improving patient identity verification and accelerating medical imaging analysis, AI technologies are addressing some of healthcare’s biggest operational challenges.
